SQ
SQZ Biotechnologies Company
SQZB · OTC
$0.02 +0.00% (+$0.00)
1M +0.00%
Market Cap $707.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.03x
P/B 0.01x
P/E N/A
Growth
26 /100
Declining Rev. growth 1.50%
Book val. growth 0.83%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 46.57%
Net margin 377.88%
FCF margin 399.79%
Quality
3 /100
Poor ROIC 81.66%
ROA 74.14%
Asset turnover 0.20x
Debt
91 /100
Low Debt/Equity 0.60x
Current ratio 3.12x
Net debt/EBITDA 0.46x
Stability
44 /100
Moderate Beta 0.32x
Rev. volatility 25.73%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SQZB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard Bernstein
Employees
53
Headquarters
Watertown
Nadcházející události
12 LIS
Earnings
Upcoming earnings report